Voyager Therapeutics, Inc.
VYGR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640266
No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Voyager Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Voyager Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Scangos George A | Director | – | Jun 11, 2026 | 1 |
| Geraghty James A | Director | – | Jun 11, 2026 | 1 |
| Pierce Glenn | Director | 16,788 | Jun 11, 2026 | 1 |
| Higgins Michael J | Director | 31,314 | Jun 11, 2026 | 1 |
| Mackey Catherine J | Director | – | Jun 11, 2026 | 1 |
| Hyman Steven | Director | – | Jun 11, 2026 | 1 |
| Colon Grace | Director | – | Jun 11, 2026 | 1 |
| Vitale Nancy | Director | – | Jun 11, 2026 | 1 |
| Onyia Jude | Director | – | Jun 11, 2026 | 1 |
| Sandrock Alfred | President and CEO | 472,549 | Apr 3, 2026 | 5 |
| Shiferman Gregory L. | SVP and General Counsel | 50,000 | Apr 3, 2026 | 2 |
| Jorgensen Nathan D. | Chief Financial Officer | 151,416 | Feb 26, 2026 | 3 |
| Swartz Robin | COO & CBO | 199,738 | Feb 26, 2026 | 4 |
| Carter Todd Alfred | Chief Scientific Officer | 145,718 | Feb 26, 2026 | 4 |
| Ferguson Toby | Chief Medical Officer | 183,914 | Feb 10, 2026 | 1 |
| Fahey Sandell Jacquelyn | Chief Legal Officer | 123,143 | Feb 24, 2025 | 0 |
| Pfreundschuh Peter P. | Chief Financial Officer | 175,669 | Feb 22, 2024 | 0 |
| Hesslein Robert W. | Senior VP & General Counsel | 102,200 | Mar 22, 2023 | 0 |
| Neurocrine Biosciences Inc | 10% Owner | 8,575,316 | Feb 24, 2023 | 0 |
| Tepper Robert I | 10% Owner | 3,185,291 | Feb 6, 2023 | 0 |
| Third Rock Ventures III, L.P. | 10% Owner | 3,185,291 | Feb 6, 2023 | 0 |
| TRV GP III, LLC | 10% Owner | 3,185,291 | Feb 6, 2023 | 0 |
| Third Rock Ventures GP III, L.P. | 10% Owner | 3,185,291 | Feb 6, 2023 | 0 |
| EcoR1 Capital, LLC | 10% Owner | 3,851,507Indirect | Jan 11, 2023 | 0 |
| Burek Julie | VP, Finance | 52,458 | Mar 23, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 (view filing)4:30 PM ET | Jan 27 | 4 days | Tepper Robert I and 3 others10% Owner | SSale | −50.0K | $9.02 | −$451.0K | −1.0%5.07M after | |
| Jan 26, 2023 (view filing)5:23 PM ET | Jan 24-25 | 2 days | Tepper Robert I and 3 others10% Owner | SSale | −150.0K | $9.25 | −$1.39M | −2.8%5.12M after | 2 lots |
| Jan 24, 2023 (view filing)6:20 PM ET | Jan 20-23 | 4 days | Tepper Robert I and 3 others10% Owner | SSale | −155.0K | $9.12 | −$1.41M | −2.9%5.27M after | 2 lots |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Hesslein Robert W.Senior VP & General Counsel | SSale | −2.19K | $9.85 | −$21.5K | −1.9%112.8K after | 2 lots |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Carter Todd AlfredChief Scientific Officer | SSale | −1.11K | $9.85 | −$10.9K | −3.1%35.1K after | 2 lots |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Swartz RobinChief Operating Officer | SSale | −2.19K | $9.85 | −$21.5K | −4.0%51.9K after | 2 lots |
| Jan 11, 2023 (view filing) | Jan 9-11 | 2 days | EcoR1 Capital, LLC10% Owner | SSale | −902.4K | $7.91 | −$7.14M | −19.0%3.85M after | 3 lots |
| Jan 10, 2023 (view filing) | Jan 6 | 4 days | Carter Todd AlfredChief Scientific Officer | SSale | −388 | $6.41 | −$2.49K | −1.1%36.2K after | |
| Aug 26, 2022 (view filing)4:15 PM ET | Aug 24-25 | 2 days | Tepper Robert I and 3 others10% Owner | SSale | −350.0K | $6.16 | −$2.16M | −6.1%5.43M after | 2 lots |
| Aug 18, 2022 (view filing)4:15 PM ET | Aug 16 | 2 days | Tepper Robert I and 3 others10% Owner | SSale | −128.5K | $6.04 | −$775.9K | −2.2%5.78M after | |
| Aug 16, 2022 (view filing)4:22 PM ET | Aug 12-15 | 4 days | Tepper Robert I and 3 others10% Owner | SSale | −483.8K | $6.10 | −$2.95M | −7.6%5.91M after | 2 lots |
| Jul 18, 2022 (view filing) | Jul 14 | 4 days | Pierce GlennDirector | SSale | −9.51K | $6.70 | −$63.7K | −36.2%16.8K after | |
| Jul 18, 2022 (view filing) | Jul 14 | 4 days | Higgins Michael JDirector | SSale | −13.9K | $6.70 | −$93.1K | −30.7%31.3K after | |
| Jun 23, 2022 (view filing) | Jun 21-23 | 2 days | EcoR1 Capital, LLC10% Owner | PPurchase | +477.4K | $5.58 | +$2.66M | +11.2%4.75M after | 2 lots |
| Apr 6, 2022 (view filing) | Apr 4 | 2 days | Swartz RobinChief Operating Officer | SSale | −1.53K | $8.25 | −$12.6K | −2.8%52.1K after | |
| Apr 6, 2022 (view filing) | Apr 4 | 2 days | Hesslein Robert W.Senior VP & General Counsel | SSale | −2.79K | $8.25 | −$23.0K | −2.4%115.0K after | |
| Mar 23, 2022 (view filing) | Mar 21 | 2 days | Swartz RobinChief Operating Officer | SSale | −4.41K | $8.29 | −$36.6K | −7.6%53.6K after | 2 lots |
| Mar 23, 2022 (view filing) | Mar 21 | 2 days | Hesslein Robert W.Senior VP & General Counsel | SSale | −4.96K | $8.29 | −$41.1K | −4.0%117.7K after | 2 lots |
| Mar 23, 2022 (view filing) | Mar 21 | 2 days | Burek JulieVP, Finance | SSale | −2.65K | $8.29 | −$22.0K | −4.8%52.5K after | 2 lots |
| Feb 22, 2022 (view filing) | Feb 17 | 5 days | Hesslein Robert W.Senior VP & General Counsel | SSale | −4.10K | $3.55 | −$14.6K | −3.2%122.7K after | |
| Feb 22, 2022 (view filing) | Feb 17 | 5 days | Burek JulieVP, Finance | SSale | −789 | $3.55 | −$2.80K | −1.4%55.1K after | |
| Feb 15, 2022 (view filing) | Feb 11 | 4 days | Hesslein Robert W.Senior VP & General Counsel | SSale | −3.25K | $3.36 | −$10.9K | −2.5%126.8K after | |
| Feb 15, 2022 (view filing) | Feb 11 | 4 days | Burek JulieVP, Finance | SSale | −361 | $3.36 | −$1.21K | −0.6%55.9K after | |
| Jan 14, 2022 (view filing) | Jan 3-12 | 11 daysLate | Burek JulieVP, Finance | SSale | −3.33K | $2.85 | −$9.48K | −6.7%46.3K after | 2 lots |